Adenosine up-regulates cyclooxygenase-2 in human granulocytes: impact on the balance of eicosanoid generation

Marc Pouliot1, Marie-Elaine Fiset, Mireille Massé

  • 1Centre de Recherche en Rhumatologie et Immunologie, Centre de Recherche du Centre Hospitalier Universitaire de Québec, and Faculté de Médecine, Université Laval, Canada. Marc.Pouliot@crchul.ulaval.ca

Insights

Adenosine enhances cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) production in polymorphonuclear neutrophils (PMNs). This suggests adenosine may limit inflammation by boosting PGE2, which inhibits PMN functions.

Area of Science:

  • Immunology
  • Biochemistry

Background:

  • Polymorphonuclear neutrophils (PMNs) are key immune cells migrating to inflammatory sites.
  • PMNs produce lipid mediators via 5-lipoxygenase and cyclooxygenase-2 (COX-2) pathways.
  • Adenosine is known for anti-inflammatory effects, particularly on the 5-lipoxygenase pathway.

Purpose of the Study:

  • To investigate the impact of adenosine on the COX-2 pathway in PMNs.
  • To elucidate adenosine's role in regulating inflammatory mediator production.

Main Methods:

  • Studied adenosine's effect on COX-2 enzyme and mRNA expression.
  • Measured prostaglandin E2 (PGE2) production in response to arachidonic acid.
  • Utilized pharmacological agents to mimic adenosine's effects and COX-2 inhibitors.
  • Investigated the role of EP(2) receptors in adenosine's regulatory effects.

Main Results:

  • Adenosine up-regulates COX-2 expression and mRNA in PMNs.
  • Adenosine increases PGE2 production, correlating with COX-2 levels.
  • Increased intracellular cAMP levels mimic adenosine's COX-2 up-regulation.
  • PGE2, via EP(2) receptors, inhibits leukotriene B4 formation when extracellular adenosine is withdrawn.

Conclusions:

  • Adenosine enhances COX-2 mediated PGE2 generation in PMNs.
  • Adenosine may promote self-limiting inflammation by increasing PGE2.
  • This study reveals a novel immunomodulatory mechanism of adenosine in leukocytes via lipid mediator balance.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...